发明申请
US20160184241A1 INTRANASAL DELIVERY OF Beta2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING COGNITION IN HUMANS WITH DOWN SYNDROME AND COMPOSITIONS THEREFOR
有权
用于改善患有下丘脑及其组合物的人类的凝集的β2-受体激动剂的内分泌递送
- 专利标题： INTRANASAL DELIVERY OF Beta2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING COGNITION IN HUMANS WITH DOWN SYNDROME AND COMPOSITIONS THEREFOR
- 专利标题（中）： 用于改善患有下丘脑及其组合物的人类的凝集的β2-受体激动剂的内分泌递送
-
申请号： US14721466申请日： 2015-05-26
-
公开(公告)号： US20160184241A1公开(公告)日： 2016-06-30
- 发明人: Ahmad SALEHI , Brian Medina , Van Dang , Devsmita Das
- 申请人： Ahmad SALEHI , Brian Medina , Van Dang , Devsmita Das
- 申请人地址： US CA Palo Alto
- 专利权人： THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
- 当前专利权人： THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
- 当前专利权人地址： US CA Palo Alto
- 主分类号： A61K31/138
- IPC分类号： A61K31/138 ; A61K9/00
摘要：
A method of improving cognition in a patient with Down syndrome, which entails intranasally administering one or more β2-ADR agonists or pharmaceutically-acceptable salts of either or both to the patient in an amount and with a frequency effective to improve cognition of the patient as measured contextual learning tests.